The HMG-domain-containing transcription factor Sox9 is an important regulator of chondrogenesis, testis formation and development of several other organs. Sox9 is expressed in the otic placodes, the primordia of the inner ear, and studies in Xenopus have provided evidence that Sox9 is required for otic specification. Here we report novel and different functions of Sox9 during mouse inner ear development. We show that in mice with a Foxg1
Introduction
The vertebrate inner ear, which contains the sensory organs for hearing and balance, develops from an ectodermal placode adjacent to the posterior hindbrain. In the mouse, otic development first becomes morphologically apparent at around the four-somite stage with the thickening of the ectoderm adjacent to rhombomeres five and six. The generation of a discernable otic placode takes place by the 10-somite stage. Between the 13-and 20-somite stage the placode invaginates giving rise to the otic pit, which forms a closed vesicle by the 21-to 29-somite stage. In the anterior ventral region of the otocyst, neuronal precursor cells delaminate to give rise to the cochleovestibular ganglion that will innervate the sensory cells of the inner ear. The otic vesicle then undergoes complex morphogenetic changes that ultimately generate the architecture of the adult inner ear (Barald and Kelley, 2004; Kiernan et al., 2002, and references therein) .
Transplantation studies in amphibians and birds have established that the competence to form an otic vesicle is initially widely present in the embryonic ectoderm, but progressively becomes restricted to the otic region as development proceeds (Noramly and Grainger, 2002) . Development of the otic placode is thought to be induced by signals from the cranial paraxial mesoderm and the hindbrain, and members of the fibroblast growth factor (FGF) family play a central role in this induction (Phillips et al., 2001; Wright and Mansour, 2003a, b) . In addition, Ladher et al. (2005) recently showed that FGF Available online at www.sciencedirect.com Developmental Biology 317 (2008) 213 -224 www.elsevier.com/developmentalbiology signals from the endoderm also contribute to otic induction, most likely by controlling Fgf expression in the mesoderm. Studies in chick and mouse have also provided evidence for involvement of Wnt signaling in otic placode induction (Ladher et al., 2000; Ohyama et al., 2006) , although such a role in zebrafish has been questioned (Phillips et al., 2004) . Placode induction is heralded by the onset of expression of a variety of genes, including the transcription factors Pax2, Pax8, Dlx5, Tbx2 and Sox9, which appear in the presumptive placodal ectoderm before the placode becomes morphologically distinct (Barald and Kelley, 2004; Kiernan et al., 2002; Noramly and Grainger, 2002) . As the development of the ear progresses to the otic vesicle stage the expression of these and other markers becomes confined to defined regions of the otic vesicle, which give rise to specific structures of the inner ear. This refinement of the gene expression patterns is also influenced by neighboring tissues including the notochord and hindbrain (Barald and Kelley, 2004; Kiernan et al., 2002) . Gene targeting experiments in the mouse have revealed essential functions of an increasing number of genes expressed in the developing ear (Barald and Kelley, 2004; Kiernan et al., 2002; Noramly and Grainger, 2002) . However, the genetic control of the earliest stages of otic morphogenesis, the invagination of the otic placode and the formation of an otic vesicle, is so far poorly understood. Sox9, a member of the SoxE subgroup of HMG-domaincontaining transcription factors, is expressed in the developing inner ear in several species Liu et al., 2003; Saint-Germain et al., 2004) . In humans, heterozygous SOX9 mutations are the cause for the skeletal malformation syndrome campomelic dysplasia, which is characterized by severe general hypoplasia of the skeleton, XY sex reversal and defects in several other organ systems including the brain, pancreas and heart (OMIM 114290). Importantly, campomelic dysplasia is frequently associated with conductive and sensorineural hearing loss, including malformations of the cochlea (Houston et al., 1983; Tokita et al., 1979) . Indeed, studies in Xenopus and zebrafish have recently provided evidence for an essential function of Sox9 in inner ear development. SaintGermain et al. (2004) demonstrated that morpholino antisense oligonucleotide-mediated depletion of Sox9 protein in Xenopus embryos resulted in loss of early otic markers and failure of otic vesicle development. They also showed that a hormoneinducible dominant negative version of Sox9 blocked otic development during gastrulation, but had little effect on otic development at later stages, indicating that Sox9 is required for otic placode specification, but not for subsequent stages of otic development. Furthermore, loss of Sox9a and Sox9b function in zebrafish resulted in a complete absence or severe reduction of the otic vesicle (Liu et al., 2003; Yan et al., 2005) . In addition to these loss-of-function studies, Taylor and Labonne (2005) recently showed that over-expression of Sox9 in Xenopus can result in enlarged or ectopic otic vesicles.
In the mouse, the function of Sox9 in otic development has so far not been examined. Here we used conditional gene targeting to inactivate Sox9 in the entire prospective otic placode or only in part of its cells. In contrast to what would have been expected based on its functions in Xenopus, we find that in mouse Sox9 is not essential for the initial otic specification and formation of a morphologically recognizable otic placode. Instead, we show that Sox9 is cell-autonomously required for placode invagination, and we provide evidence that Sox9 controls adhesive properties of placodal cells and regulates Epha4 expression.
Materials and methods

Mice
Sox9
flox/flox mice (Kist et al., 2002) were bred to Foxg1 Cre mice (Hebert and McConnell, 2000) in a mixed background. Foxg1
Cre ;Sox9 flox/+ mice were viable and fertile and were backcrossed to Sox9 flox/flox mice to obtain Foxg1
Cre ; Sox9 flox/flox embryos. Generation of K19 Cre ;Sox9 flox/flox mice has been previously described . For timed pregnancies, plugs were checked in the morning after mating, noon was taken as embryonic day (E) 0.5. Genotyping was carried out on genomic DNA derived from adult tails or embryonic yolk sacs using established PCR protocols for the Cre allele (Lecureuil et al., 2002) and for the Sox9 and Sox9 flox alleles (Kist et al., 2002) .
Histology, RNA in situ hybridization, immunostaining and electron microscopy
For whole mount RNA in situ hybridization, embryos were fixed, processed and hybridized as described by Henrique et al. (1995) . cDNAs used to generate riboprobes for Pax2, Pax8 (Dorfler and Busslinger, 1996) , Dlx5 (Liu et al., 1997) , Sox8 (Sock et al., 2001) , Sox10 (Kuhlbrodt et al., 1998) , Tbx2 (Chapman et al., 1996) , Pea3 (Taylor et al., 1997) , NeuroD (Gradwohl et al., 2000) , Fgf3 (Mansour and Martin, 1988) , Epha4 (Mori et al., 1995) and Col2a1 (Rahkonen et al., 2003) are described in the cited references. To generate a probe for Erm, a 674 bp fragment was amplified by RT-PCR from mouse embryo cDNA using the primers Erm5′ (TTG GTG CTT CAT GCT CCA CC) and Erm3′ (GTC AGC ACA GTA ATC TCG GG) and cloned into pCRII-TOPO (Invitrogen). Embryos for histological analyses were collected in PBS, fixed in Serra (ethanol/37% formaldehyde/acetic acid, 6:3:1), embedded in paraffin, sectioned at 7 μm and stained with hematoxylin and eosin. Immunostaining was performed using the Peroxidase Vectastain ABC Kit (Vector Laboratories) following the manufacturer's instructions. For immunofluorescence we used Alexa Fluor 594 rabbit anti-goat IgG (1:150), biotinylated secondary antibodies (Vector Laboratories) or the M.O.M kit (Vector Laboratories) and the Fluorescent Avidin Kit (Vector Laboratories) following the manufacturer's instructions. Primary antibodies used were: rabbit anti-Sox9 (gift of M. Wegner, Stolt et al. 2003, 1:200) , goat anti-Sox9 (Santa Cruz; sc-17341; 1:50), mouse anti-N-Cadherin (BD Biosciences, Cat# 610920, 1:100), mouse anti-E-Cadherin (BD Biosciences, Cat# 610404, 1:100), mouse anti-beta-Catenin (BD Biosciences, Cat# 610154, 1:100), rabbit anti-N-CAM (Chemicon, Cat# AB5032, 1:100), rabbit anti-Pax2 (Covance, Cat# PRB-276P, 1:100) and goat anti-EphA4 (R&D, Cat# AF641; 1:100). For fluorescence counterstaining of nuclei, DAPI (4′,6-diamidino-2-phenylindole, Molecular Probes, 100 ng/ml in PBS) was used. Detailed staining protocols are available upon request. Confocal images were captured using a Zeiss LSM 510 laser scanning microscope.
For whole mount immunohistochemistry, embryos were collected in PBS, fixed in methanol:dimethyl sulfoxide (4:1) and processed as described (Nagy et al., 2003 ) using a 1:200 dilution of the rabbit anti-Sox9 antibody.
For electron microscopy, embryos were fixed in buffered 2.5% glutaraldehyde and 2% osmiumtetroxide, and embedded in Epon 812 resin. Ultra-thin sections were stained with uranyl acetate and lead citrate and examined in a Philips CM 10 electron microscope, equipped with a Gatan Bio-scan camera Model 792.
Analysis of cell proliferation and cell death
For cell proliferation, 7 μm sections were stained with an anti-phosphohistone H3 antibody (Upstate, Cat# 06-570, 1:200) as described (http://www. ihcworld.com/_protocols/antibody_protocols/histone_h3_upstate.htm), and counterstained with hematoxylin. The number of labeled cells as well as total cell numbers per otic placode was scored.
Detection of apoptotic cells in paraffin sections was performed using either the In Situ Cell Death Detection Kit (Roche) following the producer's guidelines or using a rabbit anti-Caspase3-active antibody (R&D Systems, Cat# AF-835) as described (http://www.ihcworld.com/_protocols/antibody_protocols/caspase3_ r&d_system.htm), but using a 1:100 dilution and the Fluorescent Avidin Kit (Vector Laboratories) to perform immunofluorescence detection.
Results
Tissue specific inactivation of Sox9 in the early otic ectoderm It has previously been shown that Foxg1
Cre drives Cre activity into the prospective otic ectoderm and leads to complete recombination of floxed transgenes in the otocyst (Hebert and McConnell, 2000; Pirvola et al., 2002) . In order to generate embryos with a conditional inactivation of Sox9 in the developing inner ear, we therefore crossed mice with a floxed allele of Sox9 (Sox9 flox ; Kist et al., 2002) to mice carrying Foxg1
Cre to generate Sox9 flox/flox ;Foxg1 Cre embryos. Hebert and McConnell (2000) have shown that the genetic background and the loxP target loci both influence the recombination pattern obtained with Foxg1-Cre. We therefore first examined whether Foxg1-Cre mediated recombination leads to a complete loss of Sox9 expression, and whether recombination occurs before or after the onset of Sox9-expression. In Sox9 flox/+ , Sox9 flox/flox , or Sox9 flox/+ ;Foxg1
Cre embryos (hereafter referred to as control embryos), the first Sox9-positive cells can be detected in the prospective otic area at the four-to five-somite stage (Figs. 1a, c) . By the eightsomite stage, Sox9 is expressed in a large proportion of the cells in the otic region, and by the 10-somite stage, the entire nascent otic placode is Sox9 positive (Figs. 1e, g, i, k, dashed circle). In
Cre embryos (hereafter referred to as Sox9 mutant embryos), no Sox9-positive cells were detectable in the same region at the 10-somite stage or any later stage (Figs. 1h, j, l, dashed circle, and data not shown). In a small proportion of Sox9 mutant embryos less than 10 Sox9-positive cells were transiently detectable at the eight-somite stage (Fig. 1f , small arrows), indicating that Foxg1-Cre-mediated recombination of Sox9 largely occurs prior to the onset of Sox9 expression and that in mutant embryos the vast majority of cells in the otic region never express Sox9.
Otic placodes are specified in the absence of Sox9 in mice Recent studies in Xenopus and zebrafish have provided evidence for an essential function of Sox9 in otic placode specification (Liu et al., 2003; Saint-Germain et al., 2004) . To see whether Sox9 is required for otic specification also in mice, we examined the otic region in mutant and control embryos at the 10-12 somite stage. Hematoxylin/Eosin-stained sections revealed a thickening of the ectoderm adjacent to the hindbrain in the presumptive otic region in both control and mutant embryos (Figs. 2a, a′, b) . To further address otic specification of the thickened ectoderm, we analyzed the expression of markers of early otic development. FGF signaling is essential for otic placode induction but also plays important roles at later stages of otic development. Expression of the Ets-domain transcription factor genes Erm and Pea3 is dependent on FGF signaling in many areas of the early embryo and can thus be used as a reporter for FGF signaling activity (Firnberg and Neubuser, 2002; Raible and Brand, 2001; Roehl and Nusslein-Volhard, 2001 ). Both genes were expressed in the otic region of mutant embryos in patterns similar to control embryos, indicating that FGF signaling is not affected by the absence of Sox9 (Figs. 2c, (Noramly and Grainger, 2002 , and references therein). At the 9-to 11-somite stage, no difference in expression of Pax8, Pax2 and Dlx5 was detectable in mutant and control otic ectoderm (Figs. 2e-j, Figs. S1c-f). Expression of the transcription factor Tbx2 is also initiated during otic specification shortly after the onset of Sox9 protein expression (Fig. 2k, Fig. S2 ). Its function during inner ear development, however, has not yet been analyzed. In contrast to Pax8, Pax2 and Dlx5, expression of Tbx2 in mutant embryos was reduced and confined to a smaller domain at all stages analyzed (Fig. 2l , Figs. S1g, h). Together, these analyses indicate that a morphologically distinct otic placode expressing markers of otic specification can form in the absence of Sox9. However, Sox9 is already required at this early stage for the initiation of normal Tbx2 expression.
Sox9 is necessary for otic placode invagination
To follow the development of the inner ear in the absence of Sox9, we first examined mutant embryos at E9.5 and E11.5. At E9.5, a small otic placode that had failed to invaginate was present instead of the otic vesicle found in control littermates (Figs. 3a, b) , and by E11.5, mutants lacked all inner ear structures (Figs. 1c, d ). This finding suggests that otic development is initiated in the absence of Sox9, but that otic structures degenerate at later stages. To determine when phenotypic differences between mutant and control embryos can first be detected, we examined Hematoxylin/Eosin-stained sections of the otic region between E8.0 (10-somite stage) and E9.5 (22-somite stage). At the 10-somite stage, the otic region in both mutant and control embryos is covered by a thickened ectoderm, which forms a morphologically distinct placode by the 13-somite stage (Figs. 3e, f) . At this stage in control embryos, the placode starts to invaginate to form the otic pit (Fig. 3e) . Invagination is more pronounced at the 15-and 18-somite stages (Figs. 3g, i) , and an otic vesicle forms by the 22-somite stage (Fig. 3k) . In mutant embryos, the initial thickening of the ectoderm and the formation of a placode is normal, but placode invagination is impaired; from the 18-somite stage on, mutant placodes are also smaller than control placodes (Figs. 3f, h, j, l) .
To assess whether the failure of Sox9 mutant placodes to invaginate is an indirect consequence of the failure to maintain placode specific gene expression, we next analyzed the expression of Pax2, Pax8, Dlx5, Erm, Pea3 and Tbx2 during the process of placode invagination. At the 15-to 17-somite stage, expression of Pax2, Dlx5, and Pea3 was maintained in the non-invaginating Sox9 mutant placodes at levels similar to those in control placodes (Figs. 3m-r) . The same expression patterns were observed for Pax8 and Erm (not shown). Similar to the earlier stage, Tbx2 expression was reduced in mutant placodes (Figs. 3s, t) . Thus, the failure of mutant otic placodes to invaginate seems not to be caused by a loss of otic specification.
To see whether any neuronal precursors for the vestibular cochlear ganglion are specified in the absence of Sox9, we compared the expression of NeuroD and Fgf3 in mutant and control embryos. This analysis suggests that the first neuronal precursors for the acoustic ganglion are specified in the absence of Sox9. However, these cells are subsequently lost in most mutants (Fig. S3 ).
Sox9 controls adhesive properties of placodal cells
The molecular mechanism of otic placode invagination is poorly understood and may not be dependent on changes in the actin cytoskeleton as in other invaginating tissues. Instead, normal otic placode invagination has been suggested to depend on an attachment of the placode to the hindbrain (Visconti and Hilfer, 2002) . Such a close association of the dorso-medial part of the placode with the adjacent brain tissue is clearly visible in control embryos (Figs. 3e, g, arrowheads) but is absent in Sox9 mutants (Figs. 3f, h, asterisks) . Perturbation of the extracellular matrix including the application of blocking antibodies against laminin, a component of the basement membrane, can prevent the association of the otic primordium and the hindbrain, inhibiting subsequent placode invagination (Visconti and Hilfer, 2002) . To assay for changes in the basal lamina, we performed laminin immunohistochemistry in control and mutant embryos but could not detect any differences (Figs. 4a, b) . To further assess the integrity of the basal lamina, we examined mutant and control placodes by transmission electron microscopy, but again could not detect any differences in the appearance of the basal lamina (Figs. 4c, d, and insets) . However, we detected major differences in the structure of the placodal epithelium itself. In control placodes at both the 14-and the 17-somite stage, cells are tightly packed and very few intercellular spaces are visible (Figs. 4e, g ). In contrast, the mutant epithelium appears disorganized and contains numerous intercellular spaces, in particular in the basal half of the epithelium (Figs.  4f, h ). The disorganized epithelial structure was consistently seen in all six mutant placodes analyzed and absent from the six control placodes studied. Higher magnification reveals that adjacent cells contact each other over extended areas in control placodes, while contacts between neighboring cells in mutant placodes are restricted to focal areas (Figs. 4i, j, and insets) . Together, these results indicate that Sox9 controls adhesive properties of placodal cells.
We therefore next compared the expression of adhesion molecules in control and mutant placodes by immunofluorescence, using antibodies directed against E-cadherin, Ncadherin, beta-catenin and NCAM. Of these, strong NCAM staining was detected in the neural tube, notochord, and somites, but only weak staining close to background levels was detected in the otic placode or early otic vesicle, and this staining was similar in mutant and controls (Figs. S4g, h , and data not shown). For E-cadherin, N-cadherin, and beta-catenin we detected strong membrane associated staining in the otic placode, but we were unable to detect any difference between mutant and control placodes (Figs. S4a-f) . In contrast, analysis of protein and RNA expression of the transmembrane receptor Epha4 revealed a downregulation, but not a complete loss, in mutant placodes. This downregulation was pronounced on the protein level but was also detectable on the mRNA level at the 16 somite stage (Figs. 5c-f ). In particular, the apical accumulation of EphA4 protein observed in control placodes was completely missing in mutant placodes (Figs. 5e, f) .
Col2a1 encodes type II collagen, a major component of the vitreous and cartilage extracellular matrix, and is regulated by Sox9 in chondrogenesis (de Crombrugghe et al., 2000; Lefebvre et al., 1997) . Col2a1 expression was lost from Sox9 mutant placodes (Figs. 5g, h ), indicating that loss of Sox9 may also affect the extracellular matrix around the developing ear placode in addition to affecting cell-cell contacts.
Sox9 mutant placode cells undergo apoptosis
Since Sox9 mutants appear to lose NeuroD-positive cells at E9.5 and lack all inner ear structures at E11.5, we next examined whether the mutant otic placodes may degenerate via apoptosis. Immunostaining using antibody against activated Caspase3 and TUNEL assays (not shown) revealed no increase in apoptosis at the 14-to 16-somite stage (not shown), but a high number of apoptotic cells was present throughout the mutant otic placodes at the 18-22-somite stage (Fig. 6b) . At the same stage no or only single Caspase3-positive cells at the edge of the placode were detectable in control embryos (Fig. 6a) . In contrast, analysis of cell proliferation between the 15-and 17-somite stage revealed no significant differences between control and mutant placodes (Fig. 6c) . Therefore, the size difference between control and mutant placodes and the eventual loss of otic tissue in mutant embryos seems to be caused by increased apoptosis.
Sox9 is necessary for Sox10 expression in the otic placode
Previous studies have shown that the three members of the SoxE subfamily of Sox genes, Sox8, Sox9 and Sox10, can function redundantly in regions of co-expression, but also show cross-regulation (Chaboissier et al., 2004; Stolt et al., 2004; Taylor and Labonne, 2005) . Both Sox8 and Sox10 have been reported to be expressed in the otic vesicle in the mouse at E9.5 and E10.5, respectively (Britsch et al., 2001; Sock et al., 2001) . The onset of expression of these two genes in the mouse otic region, however, has not yet been analyzed. In Xenopus, Sox10 expression in the developing otic placode is initiated after Sox9 expression (Taylor and Labonne, 2005) . To see whether the loss of Sox9 affects expression of Sox8 and Sox10, and to evaluate whether Sox8 and Sox10 might partially compensate for the loss of Sox9 during otic placode development, we analyzed expression of Sox8 and Sox10 in Sox9 mutant and control embryos. In control embryos, weak expression of Sox10 in the developing otic placode can first be detected around the 13-somite stage, and increases in strength by the 15-somite stage (Figs. 7a, c) . In Sox9 mutants, no Sox10 expression in the otic region is detectable at these stages (Figs. 7b, d) . Thus, as in Xenopus, Sox10 expression is initiated later than Sox9 expression in the mouse, and is dependent on Sox9 function. We were unable to detect any Sox8 expression in the developing otic placode above background level by in situ hybridization or immunofluorescence at E8.5 (data not shown). Together, these results rule out the possibility that functional redundancy between SoxE genes masks any of the functions of Sox9 in early inner ear development in Sox9 mutants.
Sox9 is cell-autonomously required for otic development
To address whether Sox9 is cell-autonomously required for otic development, we used Keratin19
Cre (K19 Cre ) mice which drive Cre expression in a mosaic pattern throughout the epiblast, resulting in recombination of floxed transgenes in 20-100% of all epiblast cells at E5.5 (Means et al., 2005) . Analysis of Sox9 flox/flox ;K19 Cre/+ embryos (hereafter referred to as Sox9 mosaic embryos) at E9.5 revealed the presence of one or several micro-vesicles in the otic area (Figs. 8Aa, b) . Occasionally, vesicles of almost normal size were also observed. Interestingly, both micro-vesicles and larger vesicles are entirely formed by Sox9-positive cells (Figs. 8Ac-f) . At E8.5-E8.75 (10-to 15-somite stage), the otic placodes of Sox9 mosaic embryos contain individual Sox9-positive cells, or clusters of such cells (Figs. 8Ba-d) , which invaginate to form micro-vesicles at E9.25 (Figs. 8Be, f) . Occasionally, individual Sox9-positive cells, which apparently had failed to associate with an invaginating cluster of Sox9-positive cells, were still detectable among the Sox9-negative cells at E9.5 (Fig. 8Ac, arrows) . Both Sox9-positive and Sox9-negative cells in the mosaic otic placode express the otic markers Dlx5 and Pax2 (Fig. 8C) . However, only Pax2/Sox9-double positive cells of the placode invaginate (Figs. 8Cc-c″) . Invaginating Sox9-positive clusters of cells show a higher level of Epha4 staining and a strong accumulation of the protein on the apical side of cells which is missing from Sox9-negative regions of the placode (Fig. 8D) . TUNEL assays and immunostaining for activated Caspase3 show that the Sox9-negative cells in the mosaic placode subsequently initiate apoptosis (Fig. 8E) , similar to what is (E) Noninvaginating, Sox9-negative cells in the placode die by apoptosis. TUNEL assay (Ea) and anti-activated Caspase3 immunofluorescence (Eb) on sections through the otic region of Sox9 mosaic embryos. Note that no cell death is detected in the formed otic vesicle (Ea, arrowhead) or invaginating part of the placode (Eb, arrowhead). The sections shown in panels Ad, B, Eb) were counterstained with DAPI (blue) to label the nuclei. The scale bars in panels A, B, Ca, b, E) correspond to 100 μm, and to 20 μm in panels Cc′-c″, D).
observed after complete inactivation of Sox9 in all cells of the placode (Figs. 6b, d ). This analysis of Sox9 mosaic embryos shows that Sox9 is cell-autonomously required for the invagination of placodal cells.
Discussion
To address the role of Sox9 in the development of the murine inner ear, we have conditionally inactivated Sox9 in the prospective otic region using mice with a Foxg1
Cre allele. This approach reveals novel functions of Sox9 in inner ear development in the mouse. In the absence of Sox9, otic placodes form, but the adhesive properties of the placodal cells are severely compromised and expression of the transmembrane receptor Epha4 is downregulated. Subsequently, mutant placodes fail to invaginate and degenerate by apoptosis. By means of a second Cre line harboring the K19
Cre allele we have created embryos with a mosaic recombination of Sox9 in the otic region. In these embryos, only Sox9-positive cells invaginate, indicating that Sox9 is cell-autonomously required for the invagination of otic placode cells.
Sox9 is necessary for otic placode invagination in mice
Our finding that Sox9 is absolutely required for otic placode invagination and otic vesicle formation suggests a key function of Sox9 in this process. In the absence of Sox9, the otic placode is formed but fails to invaginate, even though Pax2, Pax8 and Dlx5, markers of otic specification, continue to be expressed. The failure of otic vesicle formation is thus not a secondary consequence of a failure to maintain otic specification in the absence of Sox9.
The molecular mechanism of otic placode invagination is poorly understood. Previous studies manipulating ATP levels or disrupting Ca 2+ transport, conditions that interfere with the interaction of cytoskeletal actin and myosin, revealed no effect on otic placode invagination (Hilfer et al., 1989) . It was therefore suggested that otic placode invagination may not be dependent on the formation of a contractile actin ring as in other invaginating tissues (Pilot and Lecuit, 2005) . Instead, it has been proposed that normal otic placode invagination requires attachment of the placode to the hindbrain (Visconti and Hilfer, 2002) . In support of this idea, perturbation of the extracellular matrix by injecting blocking antibodies against laminin or heparansulfate proteoglycans into chick embryos prevented the association of the otic primordium and the hindbrain and inhibited subsequent placode invagination (Moro-Balbas et al., 2000; Visconti and Hilfer, 2002) . However, other studies had shown that otic placodes isolated from 10-somite stage quail embryos and transplanted to the lateral trunk of chick hosts form otic vesicles at very high frequency even though they are positioned far away from the neural tube (Groves and BronnerFraser, 2000) . The importance of association of the otic placode with the hindbrain for invagination and vesicle formation in avian embryos is thus currently unclear.
Even less is known in the mouse. The analysis of Gata3 mutants provided evidence that otic vesicle formation can occur even when contact of the otic placode with the neural tube is reduced (Lillevali et al., 2006) . We detected a close association of the dorso-medial part of the placode with the adjacent brain tissue in control mouse embryos, which is absent in Sox9 mutants. But in light of the Gata3 mutant phenotype it is likely that the missing attachment of Sox9-mutant placodes to the hindbrain is not the primary reason for the block of placode invagination and subsequent otic vesicle formation. This idea is further supported by our finding that in Sox9 mosaic embryos, groups of Sox9-positive cells invaginate and form microvesicles without any contact to the hindbrain.
Our analysis of Sox9 mosaic embryos shows that Sox9 is cell-autonomously required for invagination of early placodal cells. The observation that invaginating micro-vesicles are exclusively composed of Sox9-positive cells suggests that Sox9-positive and Sox9-negative cells sort out from one another. A similar segregation of Sox9-positive and negative cells has also been observed during chondrogenesis in chimaeric embryos consisting of Sox9 −/− and Sox9 +/− cells. In these embryos, Sox9
−/− and Sox9 +/− cells were intermingled in the early skeletogenic mesenchyme, but Sox9-deficient cells were then excluded form mesenchymal condensations and cartilage primordia (Bi et al., 1999) . Such a sorting-out behavior would be expected if Sox9 controls the adhesive properties of cells. Consistent with such a function, transmission electron microscopic pictures of Sox9-mutant otic placodes revealed reduced cell-cell contacts. These changes in epithelial organization are detected more than 12 h before the onset of apoptosis in mutant placodes, and are therefore not a consequence of epithelial cell death. Since the adhesive properties of cells are important for epithelial morphogenesis (Pilot and Lecuit, 2005) it is possible that the failure of otic vesicle formation is a consequence of reduced adhesion between otic placode cells in Sox9 mutants.
In light of the observed changes in cell-cell contacts and the sorting of Sox9-positive and negative cells in mosaic placodes, the downregulation of EphA4 protein expression in Sox9 mutants is of particular interest. Members of the Eph receptor tyrosin kinase family and their membrane-tethered ligands, the ephrins, have key roles in the regulation of cell adhesion and cell migration during development (Klein, 2004; Poliakov et al., 2004) . In the hindbrain, complementary expression of Epha4 and ephrinB ligands and bi-directional signaling at the interface is thought to control rhombomere-specific cell sorting and the establishment of sharp boundaries between cell populations that do not intermingle (Cooke and Moens, 2002; Xu et al., 1999) . In addition, Eph/ephrin signaling has also been implicated in the regulation of cell segregation during somitogenesis and skeletogenesis (Durbin et al., 1998 (Durbin et al., , 2000 Compagni et al., 2003; Davy et al., 2004) . It is therefore possible that Eph/ephrin signaling also regulates the segregation of placode precursor cells from non-placode cells, and cell-cell adhesion during otic placode morphogenesis, with Sox9 as an upstream regulator. Epha4 mutant mice have been generated but have no inner ear defects (Dottori et al., 1998; Helmbacher et al., 2000) . However, this is not surprising, since Eph receptor functions are often redundant due to overlapping expression patterns of several family members and promiscuous binding affinities towards ephrin ligands. Loss of function studies in single genes have likewise so far not revealed a role of Eph/ephrin signaling in somite or hindbrain segmentation (Klein, 2004; Poliakov et al., 2004) . It will therefore be important to clarify which other members of the Eph family and which of the ephrin ligands are expressed during inner ear development and how their expression is affected by the absence of Sox9.
In addition, although the EM pictures and laminin stainings show no difference in the basement membrane of control and Sox9-mutant placodes, we can not exclude that loss of Sox9 also affects the composition of the extra-cellular matrix on the basal side of the placode, and this could indirectly affect the adhesive properties of the placodal cells. Such a function of Sox9 in regulating the extra-cellular matrix is well established for chondrogenesis. There, Sox9 regulates the expression of extracellular matrix components such as type II collagen (de Crombrugghe et al., 2000; Lefebvre et al., 1997) , and Col2a1 is also down-regulated in the Sox9-mutant otic placodes, although no defects for in inner ear development have been reported for Col2a1 knock out mice (Li et al., 1995) .
Sox9 mutant placode cells undergo apoptosis
Around E9.0, about 12 h after the first changes in the morphogenetic behavior of Sox9-mutant placodes can be seen, the non-invaginated placodal cells of Sox9 mutants start to be eliminated by apoptosis. Apoptosis of misplaced cells is a frequent phenomenon in development. It is therefore very likely that the observed cell death is an indirect consequence of the changes in epithelial organization or the failure of placode invagination. However, a direct role of Sox9 in promoting cell survival in the otic placode can not be excluded. Previous studies in avian embryos addressing otic placode commitment showed that placodes transplanted to the trunk region survived far away from the hindbrain, whether they formed an otic vesicle or not (Groves and Bronner-Fraser, 2000) . It is thus unlikely that an increased distance of the placode from a source of survival signals in the hindbrain is responsible for the observed apoptosis.
Apoptosis has also been reported after inactivation of Sox9 in trunk neural crest cells and limb mesoderm (Akiyama et al., 2002; Cheung et al., 2005) . But also in these tissues, it is unclear whether Sox9 has a direct and cell autonomous effect as a survival factor or if apoptosis is an indirect consequence of other defects.
Species-specific requirement of Sox9 in otic development
In Xenopus, depletion of Sox9 protein using morpholino antisense oligonucleotides causes the loss of early otic placode markers and prevents the formation of an otic vesicle (SaintGermain et al., 2004) . This study suggests that Sox9 has a role in the initial specification of the otic placode. In sox9a-and sox9b-compromised zebrafish, otic vesicles are missing or reduced to vestiges, and Pax2 is not expressed in the otic region. A detailed analysis of the phenotype, however, was not performed, so that it is unclear whether otic placode specification, or subsequent placode morphogenesis and survival is affected (Liu et al., 2003; Yan et al., 2005) . In contrast, the formation of a morphologically distinct placode and the normal expression of markers of otic placode specification (Pax2, Pax8, and Dlx5) and of FGF signaling (Pea3 and Erm) in our Sox9 mutants demonstrate that the specification of the otic placodes in the mouse does not require Sox9. Thus, there appear to be species-specific differences in the requirement for Sox9 in inner ear development between Xenopus and mouse. These differences correlate with differences in the timing of the onset of Sox9 expression: In Xenopus and also zebrafish, Sox9 expression in the presumptive otic placode already starts during neurulation (Liu et al., 2003; Saint-Germain et al., 2004) , whereas in the mouse Sox9 protein can first be detected at the 5-somite stage. Our results furthermore exclude that Sox8 and Sox10, the two other members of the SoxE group of the Sox gene family, substitute for mouse Sox9 in otic specification. Both genes have been shown to be expressed during mouse otic development (Britsch et al., 2001; Sock et al., 2001; Watanabe et al., 2000) and recent studies in Xenopus have shown that misexpression of either Sox9 or Sox10 results in the formation of enlarged or ectopic otocysts, demonstrating that both factors are equally potent to promote inner ear formation (Taylor and Labonne, 2005) . However, we show that expression of both genes starts only after otic placode specification, and that there is a cross regulation between Sox9 and Sox10 in mice such that Sox10 is not expressed in Sox9-deficient otic placodes. Therefore, if Sox9 has any function in the formation of the otic placode in the mouse, then redundant pathways involving genes other than SoxE genes must exist.
In summary, our analysis reveals an important novel role of Sox9 in controlling otic placode invagination in the mouse. In a recent study on the transcriptional control of Sox9 expression, we have identified an enhancer element conserved between human, mouse and pufferfish, which mediates Sox9 expression in the inner ear . Characterization of the transcription factors activating this otic enhancer on the one hand, and identification of the transcriptional targets of Sox9 in the murine otic placode on the other hand, may both contribute to a better understanding of the molecular regulation of otic placode invagination.
